Previous Close | 0.7708 |
Open | 0.7779 |
Bid | 0.7708 x 900 |
Ask | 0.8000 x 900 |
Day's Range | 0.7609 - 0.7908 |
52 Week Range | 0.6110 - 3.3000 |
Volume | |
Avg. Volume | 721,216 |
Market Cap | 9.306M |
Beta (5Y Monthly) | 3.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3410 |
Earnings Date | May 24, 2019 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for WORX
NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp (NASDAQ: WORX) today announced the signing of a 2-year service agreement extension with a highly respected Integrated Delivery Network (“IDN”) ranked in the Top 5 largest IDN’s in the United States (Definitive Healthcare List: Top 25 IDN by Net Patient Revenue). An integrated delivery network (“IDN”) is an organization with a group of allied healthcare providers along with local healthcare facilities. This current customer was previously co
New York, NY, July 06, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced that it has received final court approval to settle both the securities class action and derivative action lawsuits which were commenced in 2020. The class action was consolidated under the caption Yannes v. SCWorx Corp. (1:20-cv-03349). The settlement resolves all claims asserted against SCWorx and the other named defendant without any admission of liability or wrongdoing by the Company or any defendant.
New York, NY, July 05, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp., a Delaware corporation (the “Company”), announced that it has entered into a common stock purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Institutional Investor” or “Investor”). Under the terms and subject to the conditions of the Purchase Agreement, SCWorx will have the right, but not the obligation, to issue and sell to the Investor up to $5 million of SCWorx common stock from time-to-time over the